Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.32 USD | +4.64% | +8.92% | -35.21% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.21% | 824M | |
-2.10% | 103B | |
+1.74% | 95.28B | |
+2.74% | 22.15B | |
-16.13% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-14.93% | 16.05B | |
+4.48% | 13.68B | |
+34.09% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- JPMorgan Raises Price Target on Sage Therapeutics to $29 From $24, Maintains Overweight Rating